1
|
Junren C, Xiaofang X, Mengting L, Qiuyun X, Gangmin L, Huiqiong Z, Guanru C, Xin X, Yanpeng Y, Fu P, Cheng P. Pharmacological activities and mechanisms of action of Pogostemon cablin Benth: a review. Chin Med 2021; 16:5. [PMID: 33413544 PMCID: PMC7791836 DOI: 10.1186/s13020-020-00413-y] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2020] [Revised: 11/18/2020] [Accepted: 12/11/2020] [Indexed: 02/07/2023] Open
Abstract
Patchouli ("Guanghuoxiang") or scientifically known as Pogostemon cablin Benth, belonging to the family Lamiaceae, has been used in traditional Chinse medicine (TCM) since the time of the Eastern Han dynasty. In TCM theory, patchouli can treat colds, nausea, fever, headache, and diarrhea. Various bioactive compounds have been identified in patchouli, including terpenoids, phytosterols, flavonoids, organic acids, lignins, glycosides, alcohols, pyrone, and aldehydes. Among the numerous compounds, patchouli alcohol, β-patchoulene, patchoulene epoxide, pogostone, and pachypodol are of great importance. The pharmacological impacts of these compounds include anti-peptic ulcer effect, antimicrobial effect, anti-oxidative effect, anti-inflammatory effect, effect on ischemia/reperfusion injury, analgesic effect, antitumor effect, antidiabetic effect, anti-hypertensive effect, immunoregulatory effect, and others.For this review, we examined publications from the previous five years collected from PubMed, Web of Science, Springer, and the Chinese National Knowledge Infrastructure databases. This review summarizes the recent progress in phytochemistry, pharmacology, and mechanisms of action and provides a reference for future studies focused on clinical applications of this important plant extract.
Collapse
Affiliation(s)
- Chen Junren
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Xie Xiaofang
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Li Mengting
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Xiong Qiuyun
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Li Gangmin
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Zhang Huiqiong
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Chen Guanru
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Xu Xin
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Yin Yanpeng
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China
| | - Peng Fu
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China.
- West China School of Pharmacy, Sichuan University, 17 South Renmin Rd, 610065, Chengdu, China.
| | - Peng Cheng
- Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.
- State Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu, 610075, China.
- School of Pharmacy, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Jinniu District, Chengdu, 611137, China.
| |
Collapse
|
2
|
Grailhe P, Boutarfa‐Madec A, Beauverger P, Janiak P, Parkar AA. A label-free impedance assay in endothelial cells differentiates the activation and desensitization properties of clinical S1P 1 agonists. FEBS Open Bio 2020; 10:2010-2020. [PMID: 32810927 PMCID: PMC7530392 DOI: 10.1002/2211-5463.12951] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2020] [Revised: 08/10/2020] [Accepted: 08/13/2020] [Indexed: 11/10/2022] Open
Abstract
Sphingosine-1 phosphate receptor-1 (S1P1 ) activation maintains endothelial barrier integrity, whereas S1P1 desensitization induces peripheral blood lymphopenia. The latter is exploited in the approval and/or late-stage development of receptor-desensitizing agents targeting the S1P1 receptor in multiple sclerosis, such as siponimod, ozanimod, and ponesimod. SAR247799 is a recently described G protein-biased S1P1 agonist that activates S1P1 without desensitization and thus has endothelial-protective properties in patients without reducing lymphocytes. As SAR247799 demonstrated endothelial-protective effects at sub-lymphocyte-reducing doses, the possibility exists that other S1P1 modulators could also exhibit endothelial-protective properties at lower doses. To explore this possibility, we sought to quantitatively compare the biased properties of SAR247799 with the most advanced clinical molecules targeting S1P1 . In this study, we define the β-arrestin pathway component of the impedance profile following S1P1 activation in a human umbilical vein endothelial cell line (HUVEC) and report quantitative indices of the S1P1 activation-to-desensitization ratio of various clinical molecules. In a label-free impedance assay assessing endothelial barrier integrity and disruption, the mean estimates (95% confidence interval) of the activation-to-desensitization ratios of SAR247799, ponesimod, ozanimod, and siponimod were 114 (91.1-143), 7.66 (3.41-17.2), 6.35 (3.21-12.5), and 0.170 (0.0523-0.555), respectively. Thus, we show that SAR247799 is the most G protein-biased S1P1 agonist currently characterized. This rank order of bias among the most clinically advanced S1P1 modulators provides a new perspective on the relative potential of these clinical molecules for improving endothelial function in patients in relation to their lymphocyte-reducing (desensitization) properties.
Collapse
Affiliation(s)
- Patrick Grailhe
- Diabetes and Cardiovascular ResearchSanofi R&DChilly‐MazarinFrance
| | | | | | - Philip Janiak
- Diabetes and Cardiovascular ResearchSanofi R&DChilly‐MazarinFrance
| | - Ashfaq A. Parkar
- Diabetes and Cardiovascular ResearchSanofi US ServicesBridgewaterNJUSA
| |
Collapse
|
3
|
Anti-nociceptive effect of patchouli alcohol: Involving attenuation of cyclooxygenase 2 and modulation of mu-opioid receptor. Chin J Integr Med 2017; 25:454-461. [PMID: 28795389 DOI: 10.1007/s11655-017-2952-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2016] [Indexed: 12/31/2022]
Abstract
OBJECTIVE To explore the anti-nociceptive effect of patchouli alcohol (PA), the essential oil isolated from Pogostemon cablin (Blanco) Bent, and determine the mechanism in molecular levels. METHODS The acetic acid-induced writhing test and formalin-induced plantar injection test in mice were employed to confirm the effect in vivo. Intracellular calcium ion was imaged to verify PA on mu-opioid receptor (MOR). Cyclooxygenase 2 (COX2) and MOR of mouse brain were expressed for determination of PA's target. Cellular experiments were carried out to find out COX2 and MOR expression induced by PA. RESULTS PA significantly reduced latency period of visceral pain and writhing induced by acetic acid saline solution (P<0.01) and allodynia after intra-plantar formalin (P<0.01) in mice. PA also up-regulated COX2 mRNA and protein (P<0.05) with a down-regulation of MOR (P<0.05) both in in vivo and in vitro experiments, which devote to the analgesic effect of PA. A decrease in the intracellular calcium level (P<0.05) induced by PA may play an important role in its anti-nociceptive effect. PA showed the characters of enhancing the MOR expression and reducing the intracellular calcium ion similar to opioid effect. CONCLUSIONS Both COX2 and MOR are involved in the mechanism of PA's anti-nociceptive effect, and the up-regulation of the receptor expression and the inhibition of intracellular calcium are a new perspective to PA's effect on MOR.
Collapse
|